Management of hyperuricemia in gout: focus on febuxostat
Mattheus K Reinders1, Tim L Th A Jansen21Clinical Pharmacy, Atrium Medisch Centrum Parkstad, Heerlen, The Netherlands; 2Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The NetherlandsAbstract: Gout is the most common inflammatory arthritis in an elderly population, and can be diagnosed with ab...
Guardado en:
Autores principales: | Mattheus K Reinders, Tim L Th A Jansen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04df54d197474fc8aed671cf4ab3016b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of febuxostat in elderly female patients
por: Mizuno T, et al.
Publicado: (2014) -
Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Yousuf Waheed, et al.
Publicado: (2021) -
The Clinical Effects of Febuxostat Alone or Combined with Arthroscopic Surgery for Gout: A Single-Center Retrospective Study
por: Gong Z, et al.
Publicado: (2021) -
Risk Factors For Hyperuricemia In Chinese Centenarians And Near-Centenarians
por: Han QX, et al.
Publicado: (2019) -
Hyperuricemia as a Risk Factor for Cardiovascular Diseases
por: Ichiro Hisatome, et al.
Publicado: (2020)